Metronidazole (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metronidazole" in English language version.

refsWebsite

Global rank English rank

71nih.gov

4^th place

55doi.org

2^nd place

30web.archive.org

1^st place

19semanticscholar.org

11^th place

8^th place

4drugs.com

399^th place

333^rd place

3books.google.com

3^rd place

2clincalc.com

3,912^th place

2,496^th place

2harvard.edu

18^th place

17^th place

2pfizer.com

low place

2fda.gov

447^th place

338^th place

2tga.gov.au

3,984^th place

2,622^nd place

1canada.ca

1,712^th place

1,063^rd place

1medscape.com

719^th place

636^th place

1medicinescomplete.com

low place

1sps.nhs.uk

low place

1handle.net

102^nd place

76^th place

1who.int

195^th place

302^nd place

1pharmaceutical-journal.com

low place

1worldcat.org

5^th place

1inchem.org

4,334^th place

4,154^th place

1iarc.fr

4,025^th place

4,090^th place

1pharmacoj.com

low place

1iupui.edu

9,528^th place

6,597^th place

1gla.ac.uk

2,948^th place

1,879^th place

1leagle.com

4,919^th place

2,808^th place

1medicaldialogues.in

low place

1com.bd

low place

1rxlist.com

7,927^th place

6,815^th place

1escholarship.org

1,523^rd place

976^th place

1dvm360.com

low place

1ymaws.com

low place

1forbes.com

54^th place

48^th place

books.google.com

Corey EJ (2013). Drug discovery practices, processes, and perspectives. Hoboken, N.J.: John Wiley & Sons. p. 27. ISBN 978-1-118-35446-9. Archived from the original on 8 September 2017.
Dickman A (2012). Drugs in Palliative Care. OUP Oxford. p. 355. ISBN 978-0-19-163610-3. Archived from the original on 25 June 2022. Retrieved 29 August 2020.
Eisenstein BI, Schaechter M (2007). "DNA and Chromosome Mechanics". In Schaechter M, Engleberg NC, DiRita VJ, Dermody T (eds.). Schaechter's Mechanisms of Microbial Disease. Hagerstown, MD: Lippincott Williams & Wilkins. p. 28. ISBN 978-0-7817-5342-5.

canada.ca

health-products.canada.ca

"Flagyl Product information". health-products.canada.ca. 15 May 2024. Retrieved 17 February 2025.

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Metronidazole Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Archived from the original on 6 December 2024. Retrieved 30 August 2024.

com.bd

medex.com.bd

"Metronidazole Brands". Medex. Archived from the original on 24 November 2021. Retrieved 24 November 2021.

doi.org

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. (March 2018). "Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)". Clinical Infectious Diseases. 66 (7): e1 – e48. doi:10.1093/cid/cix1085. PMC 6018983. PMID 29462280.
Freeman CD, Klutman NE, Lamp KC (November 1997). "Metronidazole. A therapeutic review and update". Drugs. 54 (5): 679–708. doi:10.2165/00003495-199754050-00003. PMID 9360057.
Löfmark S, Edlund C, Nord CE (January 2010). "Metronidazole is still the drug of choice for treatment of anaerobic infections". Clin Infect Dis. 50 (Suppl 1): S16–23. doi:10.1086/647939. PMID 20067388.
Joesoef MR, Schmid GP, Hillier SL (January 1999). "Bacterial vaginosis: review of treatment options and potential clinical indications for therapy". Clinical Infectious Diseases. 28 (Suppl 1): S57 – S65. doi:10.1086/514725. PMID 10028110.
duBouchet L, Spence MR, Rein MF, Danzig MR, McCormack WM (March 1997). "Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis". Sexually Transmitted Diseases. 24 (3): 156–160. doi:10.1097/00007435-199703000-00006. PMID 9132982. S2CID 6617019.
Leitsch D (September 2015). "Drug Resistance in the Microaerophilic Parasite Giardia lamblia". Current Tropical Medicine Reports. 2 (3): 128–135. doi:10.1007/s40475-015-0051-1. PMC 4523694. PMID 26258002.
Zar FA, Bakkanagari SR, Moorthi KM, Davis MB (August 2007). "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity". Clinical Infectious Diseases. 45 (3): 302–307. doi:10.1086/519265. PMID 17599306.
Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK (August 2020). "Averting transmission: A pivotal target to manage amoebiasis". Chemical Biology & Drug Design. 96 (2): 731–744. doi:10.1111/cbdd.13699. PMID 32356312. S2CID 218475533.
Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. (January 2006). "A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study". BJOG. 113 (1): 65–74. doi:10.1111/j.1471-0528.2005.00788.x. PMID 16398774. S2CID 11366650.
Nori D, Cain JM, Hilaris BS, Jones WB, Lewis JL (August 1983). "Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study". Gynecologic Oncology. 16 (1): 117–28. doi:10.1016/0090-8258(83)90017-3. PMID 6884824.
Sarna JR, Furtado S, Brownell AK (November 2013). "Neurologic complications of metronidazole". The Canadian Journal of Neurological Sciences. 40 (6): 768–776. doi:10.1017/s0317167100015870. PMID 24257215.
Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. (February 1998). "A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85". Radiotherapy and Oncology. 46 (2): 135–46. doi:10.1016/s0167-8140(97)00220-x. PMID 9510041.
Iqbal SM, Murthy JG, Banerjee PK, Vishwanathan KA (April 1999). "Metronidazole ototoxicity--report of two cases". The Journal of Laryngology and Otology. 113 (4): 355–357. doi:10.1017/s0022215100143968. PMID 10474673. S2CID 45989669.
Lawford R, Sorrell TC (August 1994). "Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report". Clinical Infectious Diseases. 19 (2): 346–348. doi:10.1093/clinids/19.2.346. PMID 7986915.
Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, et al. (2007). "Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines". International Journal of Toxicology. 26 (5): 423–432. doi:10.1080/10915810701583010. PMID 17963129. S2CID 41230661.
Bendesky A, Menéndez D, Ostrosky-Wegman P (June 2002). "Is metronidazole carcinogenic?". Mutation Research. 511 (2): 133–144. Bibcode:2002MRRMR.511..133B. doi:10.1016/S1383-5742(02)00007-8. PMID 12052431.
Beard CM, Noller KL, O'Fallon WM, Kurland LT, Dahlin DC (February 1988). "Cancer after exposure to metronidazole". Mayo Clinic Proceedings. 63 (2): 147–153. doi:10.1016/s0025-6196(12)64947-7. PMID 3339906.
Thapa PB, Whitlock JA, Brockman Worrell KG, Gideon P, Mitchel EF, Roberson P, et al. (October 1998). "Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years". Cancer. 83 (7): 1461–1468. doi:10.1002/(sici)1097-0142(19981001)83:7<1461::aid-cncr25>3.0.co;2-1. PMID 9762949.
Friedman GD, Jiang SF, Udaltsova N, Quesenberry CP, Chan J, Habel LA (November 2009). "Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity". International Journal of Cancer. 125 (9): 2173–2178. doi:10.1002/ijc.24545. PMC 2759691. PMID 19585498.
Chen KT, Twu SJ, Chang HJ, Lin RS (March 2003). "Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan". American Journal of Public Health. 93 (3): 489–492. doi:10.2105/ajph.93.3.489. PMC 1447769. PMID 12604501.
Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y (August 2012). "Metronidazole-induced neurotoxicity developed in liver cirrhosis". Journal of Clinical Medicine Research. 4 (4): 295–298. doi:10.4021/jocmr893w. PMC 3409628. PMID 22870180.
Bariweni MW, Kamenebali I, Denyefa JB (15 April 2024). "Metronidazole-induced neurotoxicity: Possible central serotonergic and noradrenergic system involvement". Medical and Pharmaceutical Journal. 3 (1): 22–34. doi:10.55940/medphar202474. Archived from the original on 26 July 2024. Retrieved 26 July 2024.
Chaturvedi S, Malik MY, Rashid M, Singh S, Tiwari V, Gupta P, et al. (July 2020). "Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines". Neurotoxicology. 79: 1–10. Bibcode:2020NeuTx..79....1C. doi:10.1016/j.neuro.2020.03.002. PMID 32151614.
Cina SJ, Russell RA, Conradi SE (December 1996). "Sudden death due to metronidazole/ethanol interaction". The American Journal of Forensic Medicine and Pathology. 17 (4): 343–346. doi:10.1097/00000433-199612000-00013. PMID 8947362.
Gupta NK, Woodley CL, Fried R (October 1970). "Effect of metronidazole on liver alcohol dehydrogenase". Biochemical Pharmacology. 19 (10): 2805–2808. doi:10.1016/0006-2952(70)90108-5. PMID 4320226.
Williams CS, Woodcock KR (February 2000). "Do ethanol and metronidazole interact to produce a disulfiram-like reaction?". The Annals of Pharmacotherapy. 34 (2): 255–257. doi:10.1345/aph.19118. PMID 10676835. S2CID 21151432. the authors of all the reports presumed the metronidazole-ethanol reaction to be an established pharmacologic fact. None provided evidence that could justify their conclusions
Visapää JP, Tillonen JS, Kaihovaara PS, Salaspuro MP (June 2002). "Lack of disulfiram-like reaction with metronidazole and ethanol". The Annals of Pharmacotherapy. 36 (6): 971–974. doi:10.1345/1542-6270(2002)036<0971:lodlrw>2.0.co;2. PMID 12022894.
Kudo T, Endo Y, Taguchi R, Yatsu M, Ito K (May 2015). "Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 45 (5): 413–419. doi:10.3109/00498254.2014.990948. PMID 25470432. S2CID 26910995.
Tirkkonen T, Heikkilä P, Huupponen R, Laine K (October 2010). "Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide". Journal of Internal Medicine. 268 (4): 359–366. doi:10.1111/j.1365-2796.2010.02257.x. PMID 20698928. S2CID 45449460.
Lamp KC, Freeman CD, Klutman NE, Lacy MK (May 1999). "Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials". Clinical Pharmacokinetics. 36 (5): 353–373. doi:10.2165/00003088-199936050-00004. PMID 10384859. S2CID 37891515.
Alauzet C, Aujoulat F, Lozniewski A, Marchandin H (February 2019) [2019-02]. "A sequence database analysis of 5-nitroimidazole reductase and related proteins to expand knowledge on enzymes responsible for metronidazole inactivation". Anaerobe. 55: 29–34. doi:10.1016/j.anaerobe.2018.10.005. PMID 30315962.
Leiros HK, Kozielski-Stuhrmann S, Kapp U, Terradot L, Leonard GA, McSweeney SM (December 2004). "Structural basis of 5-nitroimidazole antibiotic resistance: the crystal structure of NimA from Deinococcus radiodurans". The Journal of Biological Chemistry. 279 (53): 55840–55849. doi:10.1074/jbc.M408044200. PMID 15492014.
Krakovka S, Ribacke U, Miyamoto Y, Eckmann L, Svärd S (11 January 2022). "Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics". Frontiers in Microbiology. 13: 834008. doi:10.3389/fmicb.2022.834008. PMC 8866875. PMID 35222342.
Alauzet C, Lozniewski A, Marchandin H (February 2019). "Metronidazole resistance and nim genes in anaerobes: A review". Anaerobe. 55: 40–53. doi:10.1016/j.anaerobe.2018.10.004. PMID 30316817. S2CID 52983319.
Smith A (March 2018). "Metronidazole resistance: a hidden epidemic?" (PDF). British Dental Journal. 224 (6): 403–404. doi:10.1038/sj.bdj.2018.221. PMID 29545544. Archived (PDF) from the original on 18 November 2023. Retrieved 2 February 2024.
Quirke V (29 December 2014). "Targeting the American market for medicines, ca. 1950s-1970s: ICI and Rhône-Poulenc compared". Bulletin of the History of Medicine. 88 (4): 654–696. doi:10.1353/bhm.2014.0075. PMC 4335572. PMID 25557515.
Dickson S (July 2019). "Effect of Evergreened Reformulations on Medicaid Expenditures and Patient Access from 2008 to 2016". Journal of Managed Care & Specialty Pharmacy. 25 (7): 780–792. doi:10.18553/jmcp.2019.18366. PMC 10398228. PMID 30799664.
Ebel K, Koehler H, Gamer AO, Jäckh R. "Imidazole and Derivatives". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a13_661. ISBN 978-3-527-30673-2.
Actor P, Chow AW, Dutko FJ, McKinlay MA. "Chemotherapeutics". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a06_173. ISBN 978-3-527-30673-2.
Kraft MY, Kochergin PM, Tsyganova AM, Shlikhunova VS (1989). "Synthesis of metronidazole from ethylenediamine". Pharmaceutical Chemistry Journal. 23 (10): 861–863. doi:10.1007/BF00764821. S2CID 38187002.
Opal SM, DePalo VA (April 2000). "Anti-inflammatory cytokines". Chest. 117 (4): 1162–72. doi:10.1378/chest.117.4.1162. PMID 10767254. S2CID 2267250.
van der Vorst EP, Döring Y, Weber C (November 2015). "Chemokines". Arterioscler Thromb Vasc Biol. 35 (11): e52–6. doi:10.1161/ATVBAHA.115.306359. PMID 26490276.
Elangbam CS, Qualls CW, Dahlgren RR (January 1997). "Cell adhesion molecules--update". Vet Pathol. 34 (1): 61–73. doi:10.1177/030098589703400113. PMID 9150551. S2CID 46474241.
Rizzo A, Paolillo R, Guida L, Annunziata M, Bevilacqua N, Tufano MA (July 2010). "Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells". Int Immunopharmacol. 10 (7): 744–50. doi:10.1016/j.intimp.2010.04.004. PMID 20399284.
Gonçalves-Santos E, Caldas I, Fernandes V, Franco L, Pelozo M, Feltrim F, et al. (August 2023). "Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo". Int Immunopharmacol. 121: 110416. doi:10.1016/j.intimp.2023.110416. PMID 37295025. S2CID 259126738.
King S, Campbell J, Rowe R, Daly ML, Moncrieff G, Maybury C (October 2023). "A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging". J Cosmet Dermatol. 22 (10): 2650–2662. doi:10.1111/jocd.15923. PMID 37550898. S2CID 260701677.
Kazemi S, Hawkes JE (June 2023). "Ocular rosacea associated with transient monocular vision loss: resolution with oral metronidazole" (PDF). Dermatol Online J. 29 (3). doi:10.5070/D329361439. PMID 37591279. S2CID 263745257. Archived (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.
Kim JS, Seo BH, Cha DR, Suh HS, Choi YS (December 2022). "Maintenance of Remission after Oral Metronidazole Add-on Therapy in Rosacea Treatment: A Retrospective, Comparative Study". Ann Dermatol. 34 (6): 451–460. doi:10.5021/ad.22.093. PMC 9763916. PMID 36478427.
Yamasaki K, Miyachi Y (December 2022). "Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan". J Dermatol. 49 (12): 1221–1227. doi:10.1111/1346-8138.16596. PMC 10092295. PMID 36177741.
Dall'Oglio F, Nasca MR, Gerbino C, Micali G (November 2022). "Advances in pharmacotherapy for rosacea: what is the current state of the art?". Expert Opin Pharmacother. 23 (16): 1845–1854. doi:10.1080/14656566.2022.2142907. PMID 36330970. S2CID 253301872.
Seidler Stangova P, Dusek O, Klimova A, Heissigerova J, Kucera T, Svozilkova P (2019). "Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis". Folia Biol (Praha). 65 (5–6): 265–274. doi:10.14712/fb2019065050265. PMID 32362310. S2CID 218491876.
Fararjeh M, Mohammad MK, Bustanji Y, Alkhatib H, Abdalla S (February 2008). "Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes". Int Immunopharmacol. 8 (2): 341–50. doi:10.1016/j.intimp.2007.10.018. PMID 18182250.
Narayanan S, Hünerbein A, Getie M, Jäckel A, Neubert RH (August 2007). "Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system". J Pharm Pharmacol. 59 (8): 1125–30. doi:10.1211/jpp.59.8.0010. PMID 17725855. S2CID 19772010.
Suárez LJ, Arce RM, Gonçalves C, Furquim CP, Santos NC, Retamal-Valdes B, et al. (April 2024). "Metronidazole may display anti-inflammatory features in periodontitis treatment: A scoping review". Mol Oral Microbiol. 39 (4): 240–259. doi:10.1111/omi.12459. PMID 38613247.
Barr SC, Bowman DD, Heller RL (July 1994). "Efficacy of fenbendazole against giardiasis in dogs". American Journal of Veterinary Research. 55 (7): 988–990. doi:10.2460/ajvr.1994.55.07.988. PMID 7978640.

drugs.com

"Metronidazole Use During Pregnancy". www.drugs.com. Archived from the original on 1 January 2017. Retrieved 1 January 2017.
"Metronidazole". The American Society of Health-System Pharmacists. Archived from the original on 6 September 2015. Retrieved 31 July 2015.
Side Effects
"Metronidazole". Drugs.com. Archived from the original on 24 June 2013.

dvm360.com

veterinarynews.dvm360.com

Hoskins JD (1 October 2001). "Advances in managing inflammatory bowel disease". DVM Newsmagazine. Archived from the original on 31 December 2013. Retrieved 28 December 2013.

escholarship.org

Kazemi S, Hawkes JE (June 2023). "Ocular rosacea associated with transient monocular vision loss: resolution with oral metronidazole" (PDF). Dermatol Online J. 29 (3). doi:10.5070/D329361439. PMID 37591279. S2CID 263745257. Archived (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

accessdata.fda.gov

"Flagyl metronidazole tablets label" (PDF). Archived (PDF) from the original on 22 January 2016. Retrieved 5 August 2015.

forbes.com

"Metronidazole For Dogs: Safe Dosages And Uses". Forbes. 11 July 2023. Retrieved 4 July 2024.

gla.ac.uk

eprints.gla.ac.uk

Smith A (March 2018). "Metronidazole resistance: a hidden epidemic?" (PDF). British Dental Journal. 224 (6): 403–404. doi:10.1038/sj.bdj.2018.221. PMID 29545544. Archived (PDF) from the original on 18 November 2023. Retrieved 2 February 2024.

handle.net

hdl.handle.net

World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.

harvard.edu

ui.adsabs.harvard.edu

Bendesky A, Menéndez D, Ostrosky-Wegman P (June 2002). "Is metronidazole carcinogenic?". Mutation Research. 511 (2): 133–144. Bibcode:2002MRRMR.511..133B. doi:10.1016/S1383-5742(02)00007-8. PMID 12052431.
Chaturvedi S, Malik MY, Rashid M, Singh S, Tiwari V, Gupta P, et al. (July 2020). "Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines". Neurotoxicology. 79: 1–10. Bibcode:2020NeuTx..79....1C. doi:10.1016/j.neuro.2020.03.002. PMID 32151614.

iarc.fr

monographs.iarc.fr

"Agents Classified by the IARC Monographs, Volumes 1–124". International Agency for Research on Cancer (IARC). 8 July 2019. Archived from the original on 6 September 2019. Retrieved 12 September 2019.

inchem.org

"Metronidazole (IARC Summary & Evaluation, Supplement7, 1987)". INCHEM2. 3 March 1998. Archived from the original on 4 August 2020. Retrieved 12 September 2019.

iupui.edu

medicine.iupui.edu

Flockhart DA (2007). "Drug Interactions: Cytochrome P450 Drug Interaction Table". Indiana University School of Medicine. Archived from the original on 10 October 2007. Retrieved 4 January 2022.

leagle.com

"G.D. SEARLE & CO. v. COMM | 88 T.C. 252 (1987) | 8otc2521326 | Leagle.com". Leagle. Retrieved 18 June 2019.

medicaldialogues.in

"Metrogyl ER". Medical Dialogues. Archived from the original on 17 April 2021. Retrieved 1 March 2021.

medicinescomplete.com

Brayfield A, ed. (14 January 2014). "Metronidazole". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 3 April 2014.^{[dead link‍]}

medscape.com

reference.medscape.com

"Flagyl, Flagyl ER (metronidazole) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 7 April 2014. Retrieved 3 April 2014.

nih.gov

pubmed.ncbi.nlm.nih.gov

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. (March 2018). "Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)". Clinical Infectious Diseases. 66 (7): e1 – e48. doi:10.1093/cid/cix1085. PMC 6018983. PMID 29462280.
Freeman CD, Klutman NE, Lamp KC (November 1997). "Metronidazole. A therapeutic review and update". Drugs. 54 (5): 679–708. doi:10.2165/00003495-199754050-00003. PMID 9360057.
Löfmark S, Edlund C, Nord CE (January 2010). "Metronidazole is still the drug of choice for treatment of anaerobic infections". Clin Infect Dis. 50 (Suppl 1): S16–23. doi:10.1086/647939. PMID 20067388.
Joesoef MR, Schmid GP, Hillier SL (January 1999). "Bacterial vaginosis: review of treatment options and potential clinical indications for therapy". Clinical Infectious Diseases. 28 (Suppl 1): S57 – S65. doi:10.1086/514725. PMID 10028110.
Huang Y, Shen C, Shen Y, Cui H (January 2024). "Assessing the Efficacy of Clotrimazole and Metronidazole Combined Treatment in Vaginitis: A Meta-Analysis". Altern Ther Health Med. 30 (1): 186–191. PMID 37773671.
duBouchet L, Spence MR, Rein MF, Danzig MR, McCormack WM (March 1997). "Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis". Sexually Transmitted Diseases. 24 (3): 156–160. doi:10.1097/00007435-199703000-00006. PMID 9132982. S2CID 6617019.
Leitsch D (September 2015). "Drug Resistance in the Microaerophilic Parasite Giardia lamblia". Current Tropical Medicine Reports. 2 (3): 128–135. doi:10.1007/s40475-015-0051-1. PMC 4523694. PMID 26258002.
Zar FA, Bakkanagari SR, Moorthi KM, Davis MB (August 2007). "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity". Clinical Infectious Diseases. 45 (3): 302–307. doi:10.1086/519265. PMID 17599306.
Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK (August 2020). "Averting transmission: A pivotal target to manage amoebiasis". Chemical Biology & Drug Design. 96 (2): 731–744. doi:10.1111/cbdd.13699. PMID 32356312. S2CID 218475533.
Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. (January 2006). "A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study". BJOG. 113 (1): 65–74. doi:10.1111/j.1471-0528.2005.00788.x. PMID 16398774. S2CID 11366650.
Nori D, Cain JM, Hilaris BS, Jones WB, Lewis JL (August 1983). "Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study". Gynecologic Oncology. 16 (1): 117–28. doi:10.1016/0090-8258(83)90017-3. PMID 6884824.
Sarna JR, Furtado S, Brownell AK (November 2013). "Neurologic complications of metronidazole". The Canadian Journal of Neurological Sciences. 40 (6): 768–776. doi:10.1017/s0317167100015870. PMID 24257215.
Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. (February 1998). "A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85". Radiotherapy and Oncology. 46 (2): 135–46. doi:10.1016/s0167-8140(97)00220-x. PMID 9510041.
Cheung MJ, Taher M, Lauzon GJ (April 2005). "Acneiform facial eruptions: a problem for young women". Canadian Family Physician. 51 (4): 527–533. PMC 1472951. PMID 15856972.
Iqbal SM, Murthy JG, Banerjee PK, Vishwanathan KA (April 1999). "Metronidazole ototoxicity--report of two cases". The Journal of Laryngology and Otology. 113 (4): 355–357. doi:10.1017/s0022215100143968. PMID 10474673. S2CID 45989669.
Lawford R, Sorrell TC (August 1994). "Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report". Clinical Infectious Diseases. 19 (2): 346–348. doi:10.1093/clinids/19.2.346. PMID 7986915.
Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, et al. (2007). "Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines". International Journal of Toxicology. 26 (5): 423–432. doi:10.1080/10915810701583010. PMID 17963129. S2CID 41230661.
Karamanakos PN (November 2008). "The possibility of serotonin syndrome brought about by the use of metronidazole". Minerva Anestesiologica. 74 (11): 679. PMID 18971895.
Bendesky A, Menéndez D, Ostrosky-Wegman P (June 2002). "Is metronidazole carcinogenic?". Mutation Research. 511 (2): 133–144. Bibcode:2002MRRMR.511..133B. doi:10.1016/S1383-5742(02)00007-8. PMID 12052431.
Beard CM, Noller KL, O'Fallon WM, Kurland LT, Dahlin DC (February 1988). "Cancer after exposure to metronidazole". Mayo Clinic Proceedings. 63 (2): 147–153. doi:10.1016/s0025-6196(12)64947-7. PMID 3339906.
Thapa PB, Whitlock JA, Brockman Worrell KG, Gideon P, Mitchel EF, Roberson P, et al. (October 1998). "Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years". Cancer. 83 (7): 1461–1468. doi:10.1002/(sici)1097-0142(19981001)83:7<1461::aid-cncr25>3.0.co;2-1. PMID 9762949.
Friedman GD, Jiang SF, Udaltsova N, Quesenberry CP, Chan J, Habel LA (November 2009). "Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity". International Journal of Cancer. 125 (9): 2173–2178. doi:10.1002/ijc.24545. PMC 2759691. PMID 19585498.
Chen KT, Twu SJ, Chang HJ, Lin RS (March 2003). "Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan". American Journal of Public Health. 93 (3): 489–492. doi:10.2105/ajph.93.3.489. PMC 1447769. PMID 12604501.
Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y (August 2012). "Metronidazole-induced neurotoxicity developed in liver cirrhosis". Journal of Clinical Medicine Research. 4 (4): 295–298. doi:10.4021/jocmr893w. PMC 3409628. PMID 22870180.
Chaturvedi S, Malik MY, Rashid M, Singh S, Tiwari V, Gupta P, et al. (July 2020). "Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines". Neurotoxicology. 79: 1–10. Bibcode:2020NeuTx..79....1C. doi:10.1016/j.neuro.2020.03.002. PMID 32151614.
Cina SJ, Russell RA, Conradi SE (December 1996). "Sudden death due to metronidazole/ethanol interaction". The American Journal of Forensic Medicine and Pathology. 17 (4): 343–346. doi:10.1097/00000433-199612000-00013. PMID 8947362.
Gupta NK, Woodley CL, Fried R (October 1970). "Effect of metronidazole on liver alcohol dehydrogenase". Biochemical Pharmacology. 19 (10): 2805–2808. doi:10.1016/0006-2952(70)90108-5. PMID 4320226.
Williams CS, Woodcock KR (February 2000). "Do ethanol and metronidazole interact to produce a disulfiram-like reaction?". The Annals of Pharmacotherapy. 34 (2): 255–257. doi:10.1345/aph.19118. PMID 10676835. S2CID 21151432. the authors of all the reports presumed the metronidazole-ethanol reaction to be an established pharmacologic fact. None provided evidence that could justify their conclusions
Visapää JP, Tillonen JS, Kaihovaara PS, Salaspuro MP (June 2002). "Lack of disulfiram-like reaction with metronidazole and ethanol". The Annals of Pharmacotherapy. 36 (6): 971–974. doi:10.1345/1542-6270(2002)036<0971:lodlrw>2.0.co;2. PMID 12022894.
Kudo T, Endo Y, Taguchi R, Yatsu M, Ito K (May 2015). "Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 45 (5): 413–419. doi:10.3109/00498254.2014.990948. PMID 25470432. S2CID 26910995.
Tirkkonen T, Heikkilä P, Huupponen R, Laine K (October 2010). "Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide". Journal of Internal Medicine. 268 (4): 359–366. doi:10.1111/j.1365-2796.2010.02257.x. PMID 20698928. S2CID 45449460.
Lamp KC, Freeman CD, Klutman NE, Lacy MK (May 1999). "Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials". Clinical Pharmacokinetics. 36 (5): 353–373. doi:10.2165/00003088-199936050-00004. PMID 10384859. S2CID 37891515.
Bergan T, Leinebo O, Blom-Hagen T, Salvesen B (1984). "Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration". Scandinavian Journal of Gastroenterology. Supplement. 91: 45–60. PMID 6588489.
Alauzet C, Aujoulat F, Lozniewski A, Marchandin H (February 2019) [2019-02]. "A sequence database analysis of 5-nitroimidazole reductase and related proteins to expand knowledge on enzymes responsible for metronidazole inactivation". Anaerobe. 55: 29–34. doi:10.1016/j.anaerobe.2018.10.005. PMID 30315962.
Leiros HK, Kozielski-Stuhrmann S, Kapp U, Terradot L, Leonard GA, McSweeney SM (December 2004). "Structural basis of 5-nitroimidazole antibiotic resistance: the crystal structure of NimA from Deinococcus radiodurans". The Journal of Biological Chemistry. 279 (53): 55840–55849. doi:10.1074/jbc.M408044200. PMID 15492014.
Krakovka S, Ribacke U, Miyamoto Y, Eckmann L, Svärd S (11 January 2022). "Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics". Frontiers in Microbiology. 13: 834008. doi:10.3389/fmicb.2022.834008. PMC 8866875. PMID 35222342.
Alauzet C, Lozniewski A, Marchandin H (February 2019). "Metronidazole resistance and nim genes in anaerobes: A review". Anaerobe. 55: 40–53. doi:10.1016/j.anaerobe.2018.10.004. PMID 30316817. S2CID 52983319.
Smith A (March 2018). "Metronidazole resistance: a hidden epidemic?" (PDF). British Dental Journal. 224 (6): 403–404. doi:10.1038/sj.bdj.2018.221. PMID 29545544. Archived (PDF) from the original on 18 November 2023. Retrieved 2 February 2024.
Quirke V (29 December 2014). "Targeting the American market for medicines, ca. 1950s-1970s: ICI and Rhône-Poulenc compared". Bulletin of the History of Medicine. 88 (4): 654–696. doi:10.1353/bhm.2014.0075. PMC 4335572. PMID 25557515.
Dickson S (July 2019). "Effect of Evergreened Reformulations on Medicaid Expenditures and Patient Access from 2008 to 2016". Journal of Managed Care & Specialty Pharmacy. 25 (7): 780–792. doi:10.18553/jmcp.2019.18366. PMC 10398228. PMID 30799664.
Opal SM, DePalo VA (April 2000). "Anti-inflammatory cytokines". Chest. 117 (4): 1162–72. doi:10.1378/chest.117.4.1162. PMID 10767254. S2CID 2267250.
van der Vorst EP, Döring Y, Weber C (November 2015). "Chemokines". Arterioscler Thromb Vasc Biol. 35 (11): e52–6. doi:10.1161/ATVBAHA.115.306359. PMID 26490276.
Elangbam CS, Qualls CW, Dahlgren RR (January 1997). "Cell adhesion molecules--update". Vet Pathol. 34 (1): 61–73. doi:10.1177/030098589703400113. PMID 9150551. S2CID 46474241.
Rizzo A, Paolillo R, Guida L, Annunziata M, Bevilacqua N, Tufano MA (July 2010). "Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells". Int Immunopharmacol. 10 (7): 744–50. doi:10.1016/j.intimp.2010.04.004. PMID 20399284.
Gonçalves-Santos E, Caldas I, Fernandes V, Franco L, Pelozo M, Feltrim F, et al. (August 2023). "Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo". Int Immunopharmacol. 121: 110416. doi:10.1016/j.intimp.2023.110416. PMID 37295025. S2CID 259126738.
King S, Campbell J, Rowe R, Daly ML, Moncrieff G, Maybury C (October 2023). "A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging". J Cosmet Dermatol. 22 (10): 2650–2662. doi:10.1111/jocd.15923. PMID 37550898. S2CID 260701677.
Kazemi S, Hawkes JE (June 2023). "Ocular rosacea associated with transient monocular vision loss: resolution with oral metronidazole" (PDF). Dermatol Online J. 29 (3). doi:10.5070/D329361439. PMID 37591279. S2CID 263745257. Archived (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.
Kim JS, Seo BH, Cha DR, Suh HS, Choi YS (December 2022). "Maintenance of Remission after Oral Metronidazole Add-on Therapy in Rosacea Treatment: A Retrospective, Comparative Study". Ann Dermatol. 34 (6): 451–460. doi:10.5021/ad.22.093. PMC 9763916. PMID 36478427.
Yamasaki K, Miyachi Y (December 2022). "Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan". J Dermatol. 49 (12): 1221–1227. doi:10.1111/1346-8138.16596. PMC 10092295. PMID 36177741.
Dall'Oglio F, Nasca MR, Gerbino C, Micali G (November 2022). "Advances in pharmacotherapy for rosacea: what is the current state of the art?". Expert Opin Pharmacother. 23 (16): 1845–1854. doi:10.1080/14656566.2022.2142907. PMID 36330970. S2CID 253301872.
Seidler Stangova P, Dusek O, Klimova A, Heissigerova J, Kucera T, Svozilkova P (2019). "Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis". Folia Biol (Praha). 65 (5–6): 265–274. doi:10.14712/fb2019065050265. PMID 32362310. S2CID 218491876.
Fararjeh M, Mohammad MK, Bustanji Y, Alkhatib H, Abdalla S (February 2008). "Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes". Int Immunopharmacol. 8 (2): 341–50. doi:10.1016/j.intimp.2007.10.018. PMID 18182250.
Jones D (September 2004). "Reactive oxygen species and rosacea". Cutis. 74 (3 Suppl): 17–20, 32–4. PMID 15499754.
Narayanan S, Hünerbein A, Getie M, Jäckel A, Neubert RH (August 2007). "Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system". J Pharm Pharmacol. 59 (8): 1125–30. doi:10.1211/jpp.59.8.0010. PMID 17725855. S2CID 19772010.
Suárez LJ, Arce RM, Gonçalves C, Furquim CP, Santos NC, Retamal-Valdes B, et al. (April 2024). "Metronidazole may display anti-inflammatory features in periodontitis treatment: A scoping review". Mol Oral Microbiol. 39 (4): 240–259. doi:10.1111/omi.12459. PMID 38613247.
Barr SC, Bowman DD, Heller RL (July 1994). "Efficacy of fenbendazole against giardiasis in dogs". American Journal of Veterinary Research. 55 (7): 988–990. doi:10.2460/ajvr.1994.55.07.988. PMID 7978640.

ncbi.nlm.nih.gov

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. (March 2018). "Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)". Clinical Infectious Diseases. 66 (7): e1 – e48. doi:10.1093/cid/cix1085. PMC 6018983. PMID 29462280.
Leitsch D (September 2015). "Drug Resistance in the Microaerophilic Parasite Giardia lamblia". Current Tropical Medicine Reports. 2 (3): 128–135. doi:10.1007/s40475-015-0051-1. PMC 4523694. PMID 26258002.
Cheung MJ, Taher M, Lauzon GJ (April 2005). "Acneiform facial eruptions: a problem for young women". Canadian Family Physician. 51 (4): 527–533. PMC 1472951. PMID 15856972.
Friedman GD, Jiang SF, Udaltsova N, Quesenberry CP, Chan J, Habel LA (November 2009). "Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity". International Journal of Cancer. 125 (9): 2173–2178. doi:10.1002/ijc.24545. PMC 2759691. PMID 19585498.
Chen KT, Twu SJ, Chang HJ, Lin RS (March 2003). "Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan". American Journal of Public Health. 93 (3): 489–492. doi:10.2105/ajph.93.3.489. PMC 1447769. PMID 12604501.
Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y (August 2012). "Metronidazole-induced neurotoxicity developed in liver cirrhosis". Journal of Clinical Medicine Research. 4 (4): 295–298. doi:10.4021/jocmr893w. PMC 3409628. PMID 22870180.
Krakovka S, Ribacke U, Miyamoto Y, Eckmann L, Svärd S (11 January 2022). "Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics". Frontiers in Microbiology. 13: 834008. doi:10.3389/fmicb.2022.834008. PMC 8866875. PMID 35222342.
Quirke V (29 December 2014). "Targeting the American market for medicines, ca. 1950s-1970s: ICI and Rhône-Poulenc compared". Bulletin of the History of Medicine. 88 (4): 654–696. doi:10.1353/bhm.2014.0075. PMC 4335572. PMID 25557515.
Dickson S (July 2019). "Effect of Evergreened Reformulations on Medicaid Expenditures and Patient Access from 2008 to 2016". Journal of Managed Care & Specialty Pharmacy. 25 (7): 780–792. doi:10.18553/jmcp.2019.18366. PMC 10398228. PMID 30799664.
Kim JS, Seo BH, Cha DR, Suh HS, Choi YS (December 2022). "Maintenance of Remission after Oral Metronidazole Add-on Therapy in Rosacea Treatment: A Retrospective, Comparative Study". Ann Dermatol. 34 (6): 451–460. doi:10.5021/ad.22.093. PMC 9763916. PMID 36478427.
Yamasaki K, Miyachi Y (December 2022). "Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan". J Dermatol. 49 (12): 1221–1227. doi:10.1111/1346-8138.16596. PMC 10092295. PMID 36177741.

dailymed.nlm.nih.gov

"Metronidazole injection, solution". DailyMed. 16 January 2023. Archived from the original on 6 September 2023. Retrieved 5 July 2023.
"Metronidazole tablet". DailyMed. 30 January 2023. Archived from the original on 6 September 2023. Retrieved 5 July 2023.
"Metronidazole Vaginal Gel, 0.75%- metronidazole gel". DailyMed. 17 June 2023. Archived from the original on 6 September 2023. Retrieved 5 July 2023.

ntp.niehs.nih.gov

National Toxicology Program (2016). "Metronidazole" (PDF). Report on Carcinogens (Fourteenth ed.). National Toxicology Program (NTP). Archived (PDF) from the original on 9 February 2020. Retrieved 9 February 2020.

pfizer.com

"Flagyl 375 U.S. Prescribing Information" (PDF). Pfizer. Archived from the original (PDF) on 7 August 2008.
"2003:Pfizer and Pharmacia Merger". Pfizer. Archived from the original on 26 June 2019. Retrieved 18 June 2019.

pharmaceutical-journal.com

Geoghegan O, Eades C, Moore LS, Gilchrist M (9 February 2017). "Clostridium difficile: diagnosis and treatment update". The Pharmaceutical Journal. Royal Pharmaceutical Society. Archived from the original on 7 March 2019. Retrieved 22 January 2018.

pharmacoj.com

Bariweni MW, Kamenebali I, Denyefa JB (15 April 2024). "Metronidazole-induced neurotoxicity: Possible central serotonergic and noradrenergic system involvement". Medical and Pharmaceutical Journal. 3 (1): 22–34. doi:10.55940/medphar202474. Archived from the original on 26 July 2024. Retrieved 26 July 2024.

rxlist.com

"Noritate (Metronidazole): Uses, Dosage, Side Effects, Interactions, Warning". RxList. Archived from the original on 8 December 2023. Retrieved 8 December 2023.

semanticscholar.org

api.semanticscholar.org

duBouchet L, Spence MR, Rein MF, Danzig MR, McCormack WM (March 1997). "Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis". Sexually Transmitted Diseases. 24 (3): 156–160. doi:10.1097/00007435-199703000-00006. PMID 9132982. S2CID 6617019.
Rawat A, Singh P, Jyoti A, Kaushik S, Srivastava VK (August 2020). "Averting transmission: A pivotal target to manage amoebiasis". Chemical Biology & Drug Design. 96 (2): 731–744. doi:10.1111/cbdd.13699. PMID 32356312. S2CID 218475533.
Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. (January 2006). "A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study". BJOG. 113 (1): 65–74. doi:10.1111/j.1471-0528.2005.00788.x. PMID 16398774. S2CID 11366650.
Iqbal SM, Murthy JG, Banerjee PK, Vishwanathan KA (April 1999). "Metronidazole ototoxicity--report of two cases". The Journal of Laryngology and Otology. 113 (4): 355–357. doi:10.1017/s0022215100143968. PMID 10474673. S2CID 45989669.
Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, et al. (2007). "Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines". International Journal of Toxicology. 26 (5): 423–432. doi:10.1080/10915810701583010. PMID 17963129. S2CID 41230661.
Williams CS, Woodcock KR (February 2000). "Do ethanol and metronidazole interact to produce a disulfiram-like reaction?". The Annals of Pharmacotherapy. 34 (2): 255–257. doi:10.1345/aph.19118. PMID 10676835. S2CID 21151432. the authors of all the reports presumed the metronidazole-ethanol reaction to be an established pharmacologic fact. None provided evidence that could justify their conclusions
Kudo T, Endo Y, Taguchi R, Yatsu M, Ito K (May 2015). "Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 45 (5): 413–419. doi:10.3109/00498254.2014.990948. PMID 25470432. S2CID 26910995.
Tirkkonen T, Heikkilä P, Huupponen R, Laine K (October 2010). "Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide". Journal of Internal Medicine. 268 (4): 359–366. doi:10.1111/j.1365-2796.2010.02257.x. PMID 20698928. S2CID 45449460.
Lamp KC, Freeman CD, Klutman NE, Lacy MK (May 1999). "Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials". Clinical Pharmacokinetics. 36 (5): 353–373. doi:10.2165/00003088-199936050-00004. PMID 10384859. S2CID 37891515.
Alauzet C, Lozniewski A, Marchandin H (February 2019). "Metronidazole resistance and nim genes in anaerobes: A review". Anaerobe. 55: 40–53. doi:10.1016/j.anaerobe.2018.10.004. PMID 30316817. S2CID 52983319.
Kraft MY, Kochergin PM, Tsyganova AM, Shlikhunova VS (1989). "Synthesis of metronidazole from ethylenediamine". Pharmaceutical Chemistry Journal. 23 (10): 861–863. doi:10.1007/BF00764821. S2CID 38187002.
Opal SM, DePalo VA (April 2000). "Anti-inflammatory cytokines". Chest. 117 (4): 1162–72. doi:10.1378/chest.117.4.1162. PMID 10767254. S2CID 2267250.
Elangbam CS, Qualls CW, Dahlgren RR (January 1997). "Cell adhesion molecules--update". Vet Pathol. 34 (1): 61–73. doi:10.1177/030098589703400113. PMID 9150551. S2CID 46474241.
Gonçalves-Santos E, Caldas I, Fernandes V, Franco L, Pelozo M, Feltrim F, et al. (August 2023). "Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo". Int Immunopharmacol. 121: 110416. doi:10.1016/j.intimp.2023.110416. PMID 37295025. S2CID 259126738.
King S, Campbell J, Rowe R, Daly ML, Moncrieff G, Maybury C (October 2023). "A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging". J Cosmet Dermatol. 22 (10): 2650–2662. doi:10.1111/jocd.15923. PMID 37550898. S2CID 260701677.
Kazemi S, Hawkes JE (June 2023). "Ocular rosacea associated with transient monocular vision loss: resolution with oral metronidazole" (PDF). Dermatol Online J. 29 (3). doi:10.5070/D329361439. PMID 37591279. S2CID 263745257. Archived (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.
Dall'Oglio F, Nasca MR, Gerbino C, Micali G (November 2022). "Advances in pharmacotherapy for rosacea: what is the current state of the art?". Expert Opin Pharmacother. 23 (16): 1845–1854. doi:10.1080/14656566.2022.2142907. PMID 36330970. S2CID 253301872.
Seidler Stangova P, Dusek O, Klimova A, Heissigerova J, Kucera T, Svozilkova P (2019). "Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis". Folia Biol (Praha). 65 (5–6): 265–274. doi:10.14712/fb2019065050265. PMID 32362310. S2CID 218491876.
Narayanan S, Hünerbein A, Getie M, Jäckel A, Neubert RH (August 2007). "Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system". J Pharm Pharmacol. 59 (8): 1125–30. doi:10.1211/jpp.59.8.0010. PMID 17725855. S2CID 19772010.

sps.nhs.uk

"Safety in Lactation: Metronidazole and tinidazole". SPS - Specialist Pharmacy Service. Archived from the original on 21 February 2020. Retrieved 22 February 2020.

tga.gov.au

"METRONIDAMED (Medsurge Pharma Pty LTD) | Therapeutic Goods Administration (TGA)". Archived from the original on 15 September 2024. Retrieved 15 September 2024.

ebs.tga.gov.au

"Metrogyl Metronidazole Product Information" (PDF). TGA eBusiness Services. Alphapharm Pty Limited. 8 May 2013. Archived from the original on 9 September 2016. Retrieved 3 April 2014.

web.archive.org

"Metronidazole Use During Pregnancy". www.drugs.com. Archived from the original on 1 January 2017. Retrieved 1 January 2017.
"METRONIDAMED (Medsurge Pharma Pty LTD) | Therapeutic Goods Administration (TGA)". Archived from the original on 15 September 2024. Retrieved 15 September 2024.
"Metronidazole injection, solution". DailyMed. 16 January 2023. Archived from the original on 6 September 2023. Retrieved 5 July 2023.
"Metronidazole tablet". DailyMed. 30 January 2023. Archived from the original on 6 September 2023. Retrieved 5 July 2023.
"Metronidazole Vaginal Gel, 0.75%- metronidazole gel". DailyMed. 17 June 2023. Archived from the original on 6 September 2023. Retrieved 5 July 2023.
"Flagyl, Flagyl ER (metronidazole) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 7 April 2014. Retrieved 3 April 2014.
"Metronidazole". The American Society of Health-System Pharmacists. Archived from the original on 6 September 2015. Retrieved 31 July 2015.
"Safety in Lactation: Metronidazole and tinidazole". SPS - Specialist Pharmacy Service. Archived from the original on 21 February 2020. Retrieved 22 February 2020.
Corey EJ (2013). Drug discovery practices, processes, and perspectives. Hoboken, N.J.: John Wiley & Sons. p. 27. ISBN 978-1-118-35446-9. Archived from the original on 8 September 2017.
Schmid G (28 July 2003). "Trichomoniasis treatment in women". Archived from the original on 1 August 2015. Retrieved 1 August 2015.
"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Metronidazole Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Archived from the original on 6 December 2024. Retrieved 30 August 2024.
Geoghegan O, Eades C, Moore LS, Gilchrist M (9 February 2017). "Clostridium difficile: diagnosis and treatment update". The Pharmaceutical Journal. Royal Pharmaceutical Society. Archived from the original on 7 March 2019. Retrieved 22 January 2018.
Dickman A (2012). Drugs in Palliative Care. OUP Oxford. p. 355. ISBN 978-0-19-163610-3. Archived from the original on 25 June 2022. Retrieved 29 August 2020.
"Flagyl metronidazole tablets label" (PDF). Archived (PDF) from the original on 22 January 2016. Retrieved 5 August 2015.
National Toxicology Program (2016). "Metronidazole" (PDF). Report on Carcinogens (Fourteenth ed.). National Toxicology Program (NTP). Archived (PDF) from the original on 9 February 2020. Retrieved 9 February 2020.
"Metrogyl Metronidazole Product Information" (PDF). TGA eBusiness Services. Alphapharm Pty Limited. 8 May 2013. Archived from the original on 9 September 2016. Retrieved 3 April 2014.
"Metronidazole (IARC Summary & Evaluation, Supplement7, 1987)". INCHEM2. 3 March 1998. Archived from the original on 4 August 2020. Retrieved 12 September 2019.
"Flagyl 375 U.S. Prescribing Information" (PDF). Pfizer. Archived from the original (PDF) on 7 August 2008.
"Agents Classified by the IARC Monographs, Volumes 1–124". International Agency for Research on Cancer (IARC). 8 July 2019. Archived from the original on 6 September 2019. Retrieved 12 September 2019.
Bariweni MW, Kamenebali I, Denyefa JB (15 April 2024). "Metronidazole-induced neurotoxicity: Possible central serotonergic and noradrenergic system involvement". Medical and Pharmaceutical Journal. 3 (1): 22–34. doi:10.55940/medphar202474. Archived from the original on 26 July 2024. Retrieved 26 July 2024.
Flockhart DA (2007). "Drug Interactions: Cytochrome P450 Drug Interaction Table". Indiana University School of Medicine. Archived from the original on 10 October 2007. Retrieved 4 January 2022.
Smith A (March 2018). "Metronidazole resistance: a hidden epidemic?" (PDF). British Dental Journal. 224 (6): 403–404. doi:10.1038/sj.bdj.2018.221. PMID 29545544. Archived (PDF) from the original on 18 November 2023. Retrieved 2 February 2024.
"2003:Pfizer and Pharmacia Merger". Pfizer. Archived from the original on 26 June 2019. Retrieved 18 June 2019.
"Metrogyl ER". Medical Dialogues. Archived from the original on 17 April 2021. Retrieved 1 March 2021.
"Metronidazole Brands". Medex. Archived from the original on 24 November 2021. Retrieved 24 November 2021.
"Noritate (Metronidazole): Uses, Dosage, Side Effects, Interactions, Warning". RxList. Archived from the original on 8 December 2023. Retrieved 8 December 2023.
Kazemi S, Hawkes JE (June 2023). "Ocular rosacea associated with transient monocular vision loss: resolution with oral metronidazole" (PDF). Dermatol Online J. 29 (3). doi:10.5070/D329361439. PMID 37591279. S2CID 263745257. Archived (PDF) from the original on 2 February 2024. Retrieved 2 February 2024.
Hoskins JD (1 October 2001). "Advances in managing inflammatory bowel disease". DVM Newsmagazine. Archived from the original on 31 December 2013. Retrieved 28 December 2013.
"Metronidazole". Drugs.com. Archived from the original on 24 June 2013.

who.int

apps.who.int

Schmid G (28 July 2003). "Trichomoniasis treatment in women". Archived from the original on 1 August 2015. Retrieved 1 August 2015.

worldcat.org

search.worldcat.org

Ryan KJ, Ahmad N, Alspaugh JA, Drew WL, Lagunoff M, Pottinger P, et al. (12 January 2018). Sherris medical microbiolog (Seventh ed.). New York: McGraw Hill LLC. ISBN 978-1-259-85981-6. OCLC 1004770160.

ymaws.com

cdn.ymaws.com

"METRONIDAZOLE (Veterinary—Systemic)" (PDF). Retrieved 4 July 2024.